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Abstract
Background:  HIV-1 is known to play a critical role in the pathogenesis of AIDS-associated
Kaposi's sarcoma (KS). However, it remains controversial whether KS cells are target cells for HIV
infection. The aim of this study was to investigate the expression of chemokine receptors in KS cell
cultures and to determine whether these cells can be infected by HIV-1.
Material and Methods:  KS-derived cells and KS-Y1 cells were investigated using RT-PCR for
the expression of CD4, CCR3, CCR5, CCR8 and CXCR4 mRNA. HIV infectivity of these cells was
determined by p24 antigen and HIV-1 RNA production, as well as by HIV-1 DNA integration.
Results and Discussion:  With the exception of CCR8 which is expressed by KS-derived spindle
cell cultures but not by KS-Y1 cells, unstimulated KS cells express no significant levels of CD4,
CCR3, CCR5 or CXCR4 mRNA. HIV infectivity assays showed that KS cells were unpermissive to
HTLVIIIB and JRFL strains. Although the expression of CXCR4 mRNA could be upregulated by
interleukin-1β , stimulation of KS cells by this cytokine did not allow infection by HIV-1.
Conclusions:  This shows that KS cells exhibit a chemokine receptor repertoire that does not
allow infection by HIV-1. Other cell types making up KS lesions, such as inflammatory cells, are
likely to represent the source of HIV-1 products cooperating to promote KS development and
progression.
Introduction
Kaposi's sarcoma (KS) is an angioproliferative disease
that has aroused considerable interest of late, as it is one
of the major tumors found in patients with the acquired
immune deficiency syndrome (AIDS). It is histologically
characterized by inflammation, prominent angiogenesis
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and proliferating spindle cells which are considered to be
the tumor cells of KS. The pathogenesis of KS is not fully
understood. The current hypothesis to explain the initia-
tion and progression of the tumor is a multi-step path-
way involving cytokine dysregulation and active
infection by human herpesvirus 8 (HHV-8) [1,2,3,4].
The extremely high frequency of KS among HIV-infected
patients, together with the particular aggressiveness of
AIDS-KS suggests that HIV plays a critical role in KS
pathogenesis [3]. Several studies point to the HIV-1 Tat
protein synergizing with growth factors to promote the
growth of AIDS-KS [5,6]. However, whether HIV can di-
rectly infect KS cells is still controversial. Delli Bovi et al.
did not detect HIV DNA in KS lesions using Southern
blot analysis [7] whereas an hybridization study demon-
strated the presence of HIV RNA transcripts in AIDS-KS
tissues within factor XIIIa dermal dendrocytes [8]. Us-
ing polymerase chain reaction (PCR), HIV-1 proviral
DNA was usually not found in spindle cells derived from
KS lesions of AIDS patients [9,10]. A single study found
that KS-derived cells can productively be infected by
HIV-1 in vitro [11]. This infection was followed by in-
creased expression of interleukin (IL)-1β  and IL-6, which
could be relevant to the pathogenesis of AIDS-related
KS, knowing the crucial role of cytokines and growth fac-
tors in the development of this tumor[1,3,5]. The ques-
tion of the infectibility of KS cells by HIV-1 raises the
question of the ways of attachment and entry of the virus
into these cells. Although CD4+ spindle-shaped cells
have been detected in AIDS-KS tissues [12], it is general-
ly assumed that KS cells do not harbor the CD4 antigen
[9,13,14]. However, it is noteworthy that many cell types
that do not express CD4, like endothelial cells, are also
infectible to various strains of HIV-1 [15].
Cellular entry of HIV is now known to require one of sev-
eral seven-transmembrane domain G-protein-coupled
receptors, principally CXCR4, an α -chemokine receptor,
and CCR5 whose natural ligands are β -chemokines
[16,17]. CXCR-4, also named fusin, functions as a core-
ceptor for T-cell-tropic HIV-1 strains. On the other hand,
CCR-5 is the most important coreceptor for M-tropic
strains which replicate in monocyte-derived macrophag-
es. The role of CCR3 and CCR8, which are other β -chem-
okine receptors, is more controversial. Interestingly,
these chemokine receptors can sometimes support viral
entry in the absence of CD4 [15,18]. Whether KS cells ex-
press these chemokine receptors and can respond to
their natural chemokine ligands is so far unknown. To
develop a more detailed understanding of these G-pro-
tein-coupled receptors in KS pathogenesis, we examined
their expression in KS-derived spindle cell cultures and
in an immortalized KS cell culture (KS-Y1). We next de-
termined whether these cells could be infected by HIV-1.
Materials and methods
Reagents
IL-1β  and LPS were obtained from Sigma (Bornem, Bel-
gium). SDF-1α  was purchased from R&D Systems
(Abingdon, UK).
Cell cultures
KS-cell cultures were derived from cutaneous KS biop-
sies from three patients with AIDS (KS-1, -2 and -3). Cell
cultures were also obtained from a renal transplant re-
cipient (KS-4) and from a patient with sporadic KS (KS-
5). Cultures were established similarly as previously de-
scribed [14,19]. Briefly, fresh lesions were minced in
small pieces and enzymatically digested with collagenase
(1 mg/ml) from Clostridium histolyticum for 90 min.
Cells were grown without additional growth factors in
minimum essential medium D-Val (Gibco, Paisley, Scot-
land) containing 10% inactivated fetal calf serum (FCS)
(Gibco), 1% glutamine, 1% non-essential amino acids,
penicillin (100 U/ml) and streptomycin (100 µg/ml).
Cells isolated from these cultures were characterized as
KS cells morphologically (spindle-shaped morphology)
and immunohistochemically (positivity for laminin, vi-
mentin, collagen IV, α -smooth muscle actin, CD13,
ICAM-1 and Bcl-2 protein, and negativity for cytokera-
tin, von Willebrand factor, ICAM-2, ELAM-1, VCAM-1,
CD4, CD34, CD40, CD45, CD68) in accordance with pre-
viously published reports [14,19]. In addition, we and
others have shown that these cells constitutively produce
a 92-kDa type IV collagenase [20] and can traverse base-
ment membranes [5,21], which suggests they have an in-
vasive phenotype and that they may adequately
represent the tumor cells of KS. The experiments pre-
sented here were performed on cell cultures between the
third and the fifteenth passage.
The KS-Y1 cell line which displays a higher proliferative
activity than cutaneous-derived KS cell cultures [10] was
provided by Dr. Y. Lunardi-Iskandar (Institute of Hu-
man Virology, Baltimore, MA). It was maintained in
RPMI (Gibco) containing 10% inactivated FCS (Gibco),
1% glutamine, 1% non-essential amino acids, 1 % sodium
pyruvate, penicillin (100 U/ml) and streptomycin (100
µg/ml). No exogenous growth factor was added.
RT-PCR for CD4, CCR3, CCR5, CCR8, CXCR4 and β  actin 
mRNA
Total RNA was isolated by using a commercially availa-
ble reagent (Tripure™, Roche Diagnostics, Brussels) fol-
lowing manufacturer's instructions. In order to avoid
amplification of contaminating genomic DNA, total RNA
was treated with 10 units of RQ1 RNase-free DNase
(Promega Corporation, Madison, WI) for 30 minutes.
DNase was then inactivated by adding 500 µl of
Tripure™, and total RNA was extracted once again. Re-BMC Dermatology (2001) 1:2 http://www.biomedcentral.com/1471-5945/1/2
verse transcription of mRNA was carried out as follows.
Eight µl of water containing 500 ng of total RNA were
added to 2 µl of oligo dT primer (0.5 µg/µl), and incubat-
ed at 65°C for 10 min. Samples were chilled on ice, and
10 µl of RT mix containing the following components
were added: 1) 4 µl 5 ×  RT buffer (250 mM Tris HCl, pH
8.3, 375 mM KCl, 15 mM MgCl2); 2) 2 µl deoxynucleotide
triphosphate mix (10 mM each); 3) 0.2 µl BSA (1 mg/ml);
4) 0.6 µl (25 U) human placental ribonuclease inhibitor
(RNAguard®, Pharmacia Biotech, Uppsala, Sweden); 5)
1 µl (200 U) M-MLV reverse transcriptase (Gibco); 6) 0.2
µl H2O; 7) 2 µl DTT (100 mM). The samples were then
incubated at 37°C for 60 min.
The PCR reaction was carried out in a 25 µl final volume
containing: 1) 5 µl (3 µl for β  actin) cDNA; 2) 1 µl sense
and 1 µl antisense primer (0.1 µg/µl each); 3) 0.5 µl de-
oxynucleotide triphosphate mix (10 mM each); 4) 2.5 µl
10 ×  PCR buffer (100 mM Tris HCl, pH 8.3, 500 mM KCl,
15 mM MgCl2); 5) 0.2 µl Taq DNA polymerase (5 U/µl)
(Roche); 6) H2O up to 25 µl. After an initial denaturation
step at 94°C for 4 min, temperature cycling was initiated
for each cycle as follows: 94°C for 20 sec, 55°C for 20 sec,
72°C for 45 sec; 35 (30 for β  actin) cycles were per-
formed, followed by a final elongation step at 72°C for 8
min. The sequences of the primers were (sense, 5'→  3')
CTGGGCAAAAAAGGGGATAC, AGTTTGT-
GCCCCCGCTGT, TGGTCCTGCCGCTGCTTG, GCCGTG-
TATGCCCTAAAGGT, GCCCTCCTGCTGACTATTCC,
GGGTCAGAAGGATTCCTATG, and (antisense, 5'→  3'),
GTGGGTGTCAGAGTTGGCAG, TGAAAAACAC-
CGCCATGA, TGCTCCCCAGTGGATCGG, ATGGCCTT-
GGTCTTGTTGTG, ACTGTGGTCTTGAGGGCCTT,
GGTCTCAAACATGATCTGGG, for CD4, CCR3, CCR5,
CCR8, CXCR4 and β  actin, respectively. The PCR prod-
ucts were run on a 2 % agarose gel, stained by ethidium
bromide and then photographed on Polaroid 667-type
film. The expected band size, checked against DNA mo-
lecular weight markers, was 309, 645, 430, 299, 236 and
237 base pairs for CD4, CCR3, CCR5, CCR8, CXCR4 and
β  actin, respectively.
Flow cytometric analysis
Cell surface expression of CXCR4 and CD4 receptors was
analyzed by flow cytometry. Briefly, 5 ×  105 cells were
suspended in ice-cold PBS, 0.1% bovine serum albumin.
Cells were incubated on ice for 20 min with the primary
44717.111 (anti-CXCR4) antibody (R&D Systems) or SK3
(anti-CD4) antibody (Becton Dickinson, San Jose, CA).
Cells were then washed twice with ice-cold PBS, 0.1% bo-
vine serum albumin and FACS analysis was done with a
FACScan flow cytometer (Becton Dickinson). Negative
controls were provided by replacing the primary anti-
body with non-immune immunoglobulin fraction.
Ca2+ mobilization assay
For measurements of intracellular calcium [Ca2+]i, the
cells were washed twice with HBBS without calcium and
magnesium (Gibco). After washing, the cells were resus-
pended at 5 ×  106/ml in HBBS and incubated for 30 min
at 37°C with 250 µM sulfinpyrazone (Sigma), 100 µg/ml
Pluronic F-127 (Molecular Probes, Eugene, OR) and 7.5
µM of the fluorescent calcium probe Fluo-3AM (Molecu-
lar Probes). After incubation, the cells were washed twice
with RPMI 1640 (Biowhitakker, Verviers, Belgium) sup-
plemented with 10% FCS and 250 µM sulfinpyrazone.
Before analysis, all samples were placed in a 37°C water
bath. After a 10 sec period acquisition on a FACScan flow
cytometer (Becton Dickinson), SDF-1α  was added from
concentration stocks in water.
HIV-1 infection assay
KS cells were seeded at 2 ×  104 cells per well in a volume
of 1 ml into 24-well microplates. The cells were incubated
for 1d to allow attachment and entry into the exponential
growth phase and were then treated with IL-1β  (50–500
pg/ml) or LPS (0.5–5 µg/ml). After 2 d incubation at
37°C in 5% CO2, the cells were inoculated with the HT-
LVIII-B T cell tropic strain or the JRFL macrophage
tropic strain (1000 TCID50/ml). Phytohemagglutinin
(PHA)-stimulated peripheral blood mononuclear cells
(PBMCs) obtained from a healthy HIV-negative donor
and inoculated with both HIV strains were used as posi-
tive control. They were cultivated in RPMI 1640 medium
containing 15 % FCS and IL-2 and were infected with
HTLVIIIB or JRFL similarly as KS cells. Non-inoculated
KS cells and PBMCs were used as negative controls. After
24 h, virus inoculum was removed, and cells were
washed 3 times with Hank's balanced salt solution to re-
move cell-free virus before replenishing the medium. In
order to measure the inoculum background, aliquots of
supernatants were removed after the last washing and
the addition of fresh medium. The HIV-pulsed cell cul-
tures were maintained for up to 3 weeks. The presence of
the p24 antigen was monitored twice a week, using an
enzyme immunoassay (Innotest HIV Ag mAb, Innoge-
netics, Ghent, Belgium). A culture was considered posi-
tive when at least 50 pg/ml p24 antigen was detected and
when a 4-fold increase in p24 antigen levels on 2 consec-
utive supernatants was observed.
To further confirm these results, similar experiments
were performed for the analysis of the production of
HIV-1 RNA. Briefly, KS cells were seeded at 105 cells per
well in a volume of 2.5 ml into 6-well plates and treated
as described above. The cells were then inoculated with
respectively 100000, 200000, and 500000 virions/ml
of the HTLVIII-B strain. HTLVIII-B-inoculated PHA-
stimulated PBMCs were used as positive controls. Non-
inoculated KS cells and PBMCs were used as negativeBMC Dermatology (2001) 1:2 http://www.biomedcentral.com/1471-5945/1/2
controls. After 2 h, virus inoculum was removed, and
cells were washed 6 times with HBBS to remove cell-free
virus before replenishing the medium. Production of
HIV RNA in culture supernatants was measured once a
week on cell-free supernatant, using the Amplicor HIV1
Monitor test version 1.5 (Roche Diagnostics, Branch-
burg, NJ).
Cells were also harvested at various time points by scrap-
ping and the presence of HIV-1 DNA was measured by
semi-quantitative polymerase chain reaction (PCR), as
previously described [22]. In order to definitively ex-
clude virus DNA integration, PCR for LTR/gag region,
which allows the detection of late reverse transcription
product, was performed as previously described [23].
Results
Chemokine receptor expression in KS-derived spindle cells 
and KS-Y1 cells
The results of the PCR assays are shown in Figure 1. KS
cells were examined for the presence of mRNA of CD4
and of the HIV-1 coreceptors CXCR4 and CCR5. The
mRNA expression of CCR3 and CCR8 was also investi-
gated. The amplified fragments of CD4 were revealed at
very low levels in RNA from KS-derived spindle cells.
There was a passage-dependent expression of these re-
ceptors, with cells at late passages exhibiting neither
CD4 nor CXCR4 detectable levels. No difference could be
evidenced between cells obtained from KS cells obtained
from AIDS and from non-AIDS patients. With the excep-
tion of CCR8, a chemokine receptor which is selectively
engaged by HHV-8-encoded vMIP-I [24], none of the
other investigated chemokine receptors was expressed at
significant levels in unstimulated KS-derived cells. The
KS-Y1 cell line, which may be regarded as a homogenous
KS cell culture [10], exhibited barely detectable levels of
CD4 mRNA and none of the investigated chemokine re-
ceptor mRNA. All PCR performed, except the water con-
trols, were positive for β -actin, showing the presence of
amplifiable cDNA.
The cell surface expression of CXCR-4 and CD4 was then
evaluated by FACS analysis by using the specific anti-
CXCR-4 monoclonal antibody 44717.111 and anti-CD4
monoclonal antibody SK3. This indicated that neither
KS-derived spindle cells nor KS-Y1 cells exhibited signif-
icant expression of CXCR4 receptors on their surface
(Fig. 2). Confirming previous studies, we also found that
KS cells do not harbor the CD4 receptor on their surface
(data not shown)[14].
To further determine whether KS cells were devoid of
functional CXCR4 receptor, our subsequent studies used
SDF-1α  to assess its ability to induce changes in intracel-
lular levels of Ca2+. By contrast to T cells which are
known to express CXCR4 and to be responsive to its lig-
and, KS cells exhibited no significant elevation of [Ca2+]i
after treatment with SDF-1α  (10 -1000 nM) (data not
shown).
Since inflammatory cytokines regulate the transcription
of several chemokine receptors [25] and are known to
play a role in KS pathogenesis through autocrine and
paracrine loops, we examined the effects of inflammato-
ry mediators on CCR3, CCR5, CCR8 and CXCR4 mRNA
expression in KS cells. Using commercially available
ELISA kits (BioSource, Fleurus, Belgium), we found that
the treatment of KS-derived cells with IL-1β  induced a
dose-dependent release of IL-6 and IL-8, indicating ef-
fective stimulation of the cells (data not shown). As
shown in Fig. 1, IL-1β  caused an increase in steady state
levels of CXCR4 mRNA in KS-derived spindle cells but
not in the KS-Y1 cell line. Maximal increase in CXCR4
levels was reached within 8 h after treatment. The IL-1β -
induced expression of CXCR4 mRNA was passage-de-
pendent, with stimulated cells at late passages (> 10) ex-
pressing fewer transcripts than cells at early passages.
We then investigated whether IL-1β  could induce the ex-
pression of functional CXCR4 receptor on cell cultures at
Figure 1
RT-PCR for CD4, CCR3, CCR5, CCR8, CXCR4 and β
actin mRNA detection in KS cells. RT-PCR was per-
formed on total RNA extracted from KS-2 cells at early and
late passages (passages 4 and 12, respectively) and from KS-
Y1 cells, as described in the Materiel and Methods section.
Lanes 1, non-stimulated cells; lanes 2 and 3, cells were stimu-
lated for 8 hours with 80 pg/ml IL-1β  (lanes 2) or 4 hours
with 1 µg/ml LPS (lanes 3); lanes 4, positive controls for RT-
PCR, consisting in RT-PCR performed on total RNA
extracted from T cells (positive controls for CD4, CCR8,
CXCR4 and β  actin), LPS-stimulated macrophages (positive
control for CCR5) and CHO cells transfected with the
CCR3 gene (positive control for CCR3). Similar results were
obtained with KS-1, -3, -4 and -5 cells (data not shown).BMC Dermatology (2001) 1:2 http://www.biomedcentral.com/1471-5945/1/2
passage > 10. Flow cytometry analysis revealed no signif-
icant surface expression of CXCR4 after stimulation (Fig.
2), suggesting absence of translation into surface protein
expression or expression below flow cytometry sensitivi-
ty levels. Similarly, IL-1β -stimulated KS cells exhibited
no significant elevation of [Ca2+]i after treatment with
SDF-1α  (10 -1000 nM) (data not shown). No effect of IL-
1β  was evidenced on the levels of CD4, CCR3, CCR5 and
CCR8 mRNA. LPS achieved similar effects as IL-1β  (Fig.
1).
Sensitivity of KS-derived spindle cells and KS-Y1 cells to 
HIV-1 infection
We investigated the ability of HTLVIII-B and JRFL
strains to infect KS-Y1 cells and KS spindle cells. Three
independent infection attempts for each cell type indi-
cated that HIV-1 RNA and p24 antigen production never
rose above background values, even after stimulation
with IL-1β  or LPS. There was also no HIV-1 proviral DNA
integration as assessed by semi-quantitative PCR DNA
as well as by PCR for LTR/gag region (Fig. 3). No cyto-
pathic effect could be detected.
Discussion
In vitro establishment of KS-derived spindle cell cultures
have allowed to show that the aggressive behavior of
AIDS-associated KS may be related to HIV-1 products
synergizing with growth factors to promote the growth of
KS cells [3,5]. However, direct infection of KS cells by
HIV-1 remains controversial. In addition to the CD4 an-
tigen, chemokine receptors have emerged as important
portals of entry for HIV-1 infection [16,17]. In this report,
we found that KS-derived cell cultures and the KS-Y1 cell
line express barely detectable levels of CD4 and CXCR4
mRNA. As there was a passage-dependent expression of
these receptors, it is suggested that their expression may
be related to non-KS cells co-isolated and co-cultured
with KS cells during early cell culture passages. CCR8, a
β -chemokine receptor whose role as HIV co-receptor re-
mains unclear [26], was expressed by KS-derived spindle
cells but not by the KS-Y1 cell line, which may stress the
controversy regarding the ontogenic origin of this cell
line. By contrast, neither CCR3 nor CCR5 were expressed
by unstimulated KS cells. As KS is thought to be an in-
flammatory cytokine-mediated disease, at least in the
early stage of tumor development [1,3], we tested the
possibility that these receptors would be expressed un-
der conditions of immune stimulation. One of the most
important inflammatory cytokine involved KS pathogen-
esis is IL-1β , a pleiotropic cytokine that is synthetized
during a broad variety of antigenic stimuli, including vi-
ral infections. IL-1β  levels are known to be elevated in
homosexual men with HIV-1 infection, which may, at
least partly, explain the more aggressive course of KS in
these individuals as compared with people with classic
KS. Analogously, increased IL-1β  levels might be in-
Figure 2
Flow cytometric analysis of CXCR4. (A) KS-2 cells. (B)
IL-1β -stimulated KS-2 cells. (C) T cells. Thin curve, control
isotype; thick curve, anti-CXCR4 antibody. Similar results
were obtained with KS-1 and -5 cells (data not shown).
Figure 3
PCR for LTR/gag region (detection of late reverse
transcription products). PCR were performed on DNA
extracted from cell cultures 21 days after infection attempt.
Lane 1, positive control for PCR (DNA extracted from
PBMC from a HIV-1-infected patient); lane 2, PCR negative
control (water); lanes 3 to 6, DNA extracted from PBMC
from a HIV-1-negative donor, exposed to 0, 100000, 200000
or 500000 virions respectively; lanes 7 to 10, DNA from
KSY-1 cells exposed to 0, 100000, 200000 or 500000 virions
respectively; lanes 11 to 14, DNA from KS-2 cells exposed
to 0, 100000, 200000 or 500000 virions respectively; lane 15,
DNA molecular weight marker.BMC Dermatology (2001) 1:2 http://www.biomedcentral.com/1471-5945/1/2
volved in the reported development and/or progression
of KS during opportunistic infections [1,3,27]. Here, we
found that IL-1β  induced the expression of significant
CXCR4 mRNA levels in KS cells at early passages and in-
duced its expression at low levels in KS cells at late pas-
sages. A possible explanation for this passage-dependent
induction of CXCR4 mRNA expression is that the effect
of IL-1 reflects effects on cell types making up KS lesions
and co-isolated with KS cells. For example, IL-1β  has
been shown to modulate the transcription of CXCR4 in
endothelial cells [25]. Accordingly, the KS-Y1 cell line,
which may be regarded as a homogenous KS cell culture
[10], did not express CXCR4 after stimulation with IL-1β .
Thus, to avoid misinterpretation with other cell types
making up KS lesions [9], we investigated whether IL-1β
could induce the expression of functional CXCR4 recep-
tor on cell cultures at late passages. This indicated that
IL-1β  failed to induce CXCR4 on the cell surface at signif-
icant levels, suggesting absence of translation into sur-
face protein expression or expression below flow
cytometry sensitivity levels. Absence of functional
CXCR4 receptor on KS cell surface was further demon-
strated by absence of intracellular calcium mobilization
with the CXCR4 ligand SDF-1α . No effect of IL-1β  was
evidenced on the levels of CD4, CCR3, CCR5 and CCR8
mRNA.
To test the possibility that HIV-1 could infect KS cells in-
dependently of these known HIV-1 receptors and co-re-
ceptors, we performed in vitro infectivity assays. Neither
KS-derived spindle cells nor KS-Y1 cells, could be pro-
ductively infected by HIV-1 in vitro, as evidenced by the
absence of production of HIV-1 RNA and p24 antigen as
well as the absence of HIV-1 proviral DNA integration.
KS-derived cells co-cultured with IL-1β  remained unper-
missive to HIV-1. As HIV is known to exert direct cyto-
pathic effects on infected cells, the absence of receptors
for viral entry may represent a mechanism that allows KS
cells to escape from lysis.
Conclusions
From our data, we conclude that KS cells exhibit a chem-
okine receptor repertoire that does not allow infection by
HIV-1. Other cell types making up KS lesions, such as in-
flammatory cells, are likely to represent the source of
HIV-1 products cooperating to promote KS development
and progression.
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